- : Ms Word, Ms Word Format
- : 60 Pages
- : ₦10,000
- : 1-5 Chapters
- Click to DOWNLOAD Materials
ASSESSING THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY VALUATION AND INVESTMENT ATTRACTIVENESS.
Abstract:
The emergence of financial technology (fintech) has revolutionized various industries, and the pharmaceutical sector is no exception. This study aims to assess the impact of fintech on pharmaceutical company valuation and investment attractiveness. By examining the intersection of these two sectors, the research explores the potential benefits and challenges brought about by fintech in pharmaceutical companies.
The study employs a mixed-methods approach, combining both quantitative and qualitative analyses. In the quantitative phase, financial data from pharmaceutical companies are collected and analyzed to determine the correlation between fintech adoption and company valuation metrics, such as market capitalization, revenue growth, and profitability. Additionally, statistical models will be utilized to identify the specific fintech factors that significantly influence pharmaceutical company valuation.
In the qualitative phase, interviews and surveys will be conducted with key stakeholders, including pharmaceutical company executives, investors, and fintech experts. These qualitative insights will provide a deeper understanding of the mechanisms through which fintech impacts pharmaceutical company valuation and investment attractiveness. The interviews will focus on exploring the specific fintech applications and strategies adopted by pharmaceutical companies, as well as the perceived benefits and challenges associated with fintech integration.
The findings of this research are expected to shed light on the ways in which fintech innovations are transforming the pharmaceutical industry. The study will identify the fintech factors that positively contribute to pharmaceutical company valuation and investment attractiveness, providing valuable insights for investors and pharmaceutical executives seeking to leverage fintech for strategic decision-making. Moreover, the research will highlight the potential risks and challenges associated with fintech adoption in the pharmaceutical sector, thereby guiding companies in managing these complexities effectively.
Ultimately, this study aims to contribute to the existing literature on the intersection of fintech and the pharmaceutical industry, providing a comprehensive assessment of the impact of fintech on company valuation and investment attractiveness. The research will offer valuable insights to various stakeholders, enabling them to make informed decisions regarding fintech integration, investment strategies, and long-term competitiveness in the pharmaceutical sector.
ASSESSING THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY VALUATION AND INVESTMENT ATTRACTIVENESS.GET MORE MASTERS COMPUTER SCIENCE
